Sign in

CIK 0001640266 · Accelerated filer<br>Smaller reporting company

Voyager Therapeutics, Inc.

Sign in to watch
Ticker
VYGR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857-259-5340
Business address
75 HAYDEN AVENUE, LEXINGTON, MA, 02421
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-06-05 Higgins Michael J Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2024-06-05 GERAGHTY JAMES A Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2024-06-05 Colon Grace Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2024-04-02 Swartz Robin Chief Operating Officer Sale −1,357 $9.88 $13K 117,004
2024-04-02 Sandrock Alfred President and CEO Sale −12,115 $9.86 $119K 322,839
2024-04-01 Ferguson Toby Chief Medical Officer Grant or award +105,000 105,000
2024-03-25 Ferguson Toby Chief Medical Officer Grant or award · Stock Option (Right to Buy) +210,000 210,000
2024-02-21 Swartz Robin Chief Operating Officer Sale −3,966 $7.45 $30K 118,361
2024-02-21 Sandrock Alfred President and CEO Sale −13,033 $7.46 $97K 334,954
2024-02-21 PFREUNDSCHUH PETER P. Chief Financial Officer Sale −3,764 $7.46 $28K 175,669
2024-02-21 Carter Todd Alfred Chief Scientific Officer Sale −3,365 $7.47 $25K 87,627
2024-02-20 Carter Todd Alfred Chief Scientific Officer Sale −602 $7.68 $5K 90,992
2024-02-09 Fahey Sandell Jacquelyn Chief Legal Officer Grant or award +31,000 92,000
2024-02-09 Fahey Sandell Jacquelyn Chief Legal Officer Grant or award · Stock Option (Right to Buy) +62,000 62,000
2024-02-09 Carter Todd Alfred Chief Scientific Officer Grant or award +38,500 91,594
2024-02-09 Carter Todd Alfred Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +77,000 77,000
2024-02-09 Swartz Robin Chief Operating Officer Grant or award +50,000 122,327
2024-02-09 Swartz Robin Chief Operating Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2024-02-09 Sandrock Alfred President and CEO Grant or award +130,000 347,987
2024-02-09 Sandrock Alfred President and CEO Grant or award · Stock Option (Right to Buy) +260,000 260,000

Page 5 of 7 · 130 trades